Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone for prevention of post-stroke dementia
ChiCTR-PRC-13003208Phase 4Completed
- Sponsor
- Army Specialized Medical Center
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of edaravone in Post-stroke dementia (PSD) and Mild Cognitive Impairment (MCI) (4 arms), sponsored by Army Specialized Medical Center. Primary endpoints: Mini-Mental State Examination, Imaging detection and 6 more. Started Apr 2013; status: completed.
02
Drugs
edaravone
03
Conditions
Post-stroke dementia (PSD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on ChiCTR-PRC-13003208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-13003208.